WESTFORD, Mass., Sept. 16 /PRNewswire-FirstCall/ — Cynosure,
Inc. (Nasdaq:
CYNO), a leading developer and manufacturer of a broad array of
light-based aesthetic treatment systems, today announced that it
will present at the UBS Global Life Sciences Conference in New York
on Tuesday, September 21.
The presentation by President and Chief Executive Officer
Michael Davin and Executive Vice President, Treasurer and Chief
Financial Officer Timothy Baker is scheduled to begin at 3:00 p.m.
ET on September 21. To access the live or archived webcast
of the event, visit the “Investor Relations” section of Cynosure’s
website, www.cynosure.com.
About Cynosure, Inc.Cynosure, Inc. develops and
markets aesthetic treatment systems that are used by physicians and
other practitioners to perform non-invasive and minimally invasive
procedures to remove
hair,
treat vascular and pigmented lesions, rejuvenate
the skin, liquefy
and remove unwanted fat through laser lipolysis and
temporarily reduce the appearance of cellulite. Cynosure’s
products include a broad range of laser and other light-based
energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode
lasers, as well as intense pulsed light. Cynosure was founded in
1991. For corporate or product information, contact Cynosure
at 800-886-2966, or visit www.cynosure.com.Conta
‘/>”/>
SOURCE